The funding issue was oversubscribed by 2.7 times and facilitated by InCred, with the company being valued at INR 1,000 crore (around USD 120 million).

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Not all flavoured condoms are created equal. Some sell more in south India, while others have found a niche in the north, per ...

Innov8 funding round was led by prominent family offices, including those of Mankind Pharma, Gauri Khan, Rupa Group and ...

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its ...

Family offices, including those of Mankind Pharma, Gauri Khan, Rupa Group, and Jagruti Dalmia, led the round, contributing 55 ...

The funding round was led by family offices, including those of Mankind Pharma, Gauri Khan, Rupa Group, and Jagruti Dalmia.

The round was led by prominent family offices, including those of Mankind Pharma, Gauri Khan, Rupa Group and Jagruti Dalmia.

John, ENO, and Signify are leveraging the scale of this massive event to provide essential services, promote awareness, and ...

IST, the barometer index, the S&P BSE Sensex, tumbled 499.19 points or 0.66% to 75,692.19. The Nifty 50 index declined 160.40 points or 0.69% to 22,934.70.

The stock market plunged during the early trading hours dragged down by media, mid and small cap healthcare, IT and telecom ...

India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.